S614-118

Introduced

To codify the temporary scheduling order for fentanyl-related substances by adding fentanyl-related substances to schedule I of the Controlled Substances Act.

118th Congress Introduced Mar 1, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill creates placement of fentanyl-related substances in schedule I Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. It relies on definition changes, grants, and exemptions. The main policy areas are Healthcare and Healthcare Consumers.

Who Benefits and How

Patients and health care consumers affected by the bill could face lower compliance burdens.

Who Bears the Burden and How

Public beneficiaries or protected communities affected by the clause could face increased risk.

Key Provisions

  • Creates placement of fentanyl-related substances in schedule I Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill creates placement of fentanyl-related substances in schedule I Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C.

Key Policy Areas

Healthcare, Healthcare Consumers

Primary Purpose

The bill creates placement of fentanyl-related substances in schedule I Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C.

Policy Domains

Healthcare Healthcare Consumers

Whole bill

Identified Gains
  • Patients and health care consumers affected by the bill
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: is
Patients and health care consumers affected by the bill:
Identified Costs
  • Public beneficiaries or protected communities affected by the clause
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: is
Public beneficiaries or protected communities affected by the clause:

Legislative Progress

Introduced
Introduced Committee Passed
Mar 1, 2023

Mr. Cotton (for himself, Mr. Graham, Mr. McConnell, Mr. Kennedy, …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Healthcare Consumers

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology